Telemetry as a Tool to Measure Sedative Effects of a Valerian Root Extract and Its Single Constituents in Mice

Abstract

Valeriana officinalis L. is a popular herbal treatment for mild sleep disorders. Clinical and non-clinical studies found contradictory results for valerian extracts and single constituents regarding the influence on sleep parameters. It was the aim of this study to investigate the sedative effects of a valerian root extract. Therefore, locomotor activity and core body temperature were recorded in male mice using radiotelemetry. A 70 % ethanolic extract prepared from the roots of V. officinalis (s. l.) and some of its single constituents, valerenic acid, linarin, and apigenin, were tested for effects on locomotion and body temperature over 180 minutes after oral administration. The extract was tested in a dose range of 250–1000 mg/kg, and only a dose of 1000 mg/kg valerian extract showed a mild short-term sedative effect with reduced locomotor activity between 66–78 min minutes after administration. Paradoxically, an increased activity was observed after 150 minutes after gavage. A dose of 1 mg/kg valerenic acid produced an intermittent stimulation of activity. However, a mild short-term sedative effect was found for linarin at 12 mg/kg and apigenin at 1.5 mg/kg. Considering the cumulative locomotor activity over the observation period of 180 min, it is concluded that neither the extract nor one of the compounds had considerable sedative effects. More precisely, the observed short-term changes in activity pattern indicate that valerian extract as well as the flavonoids linarin and apigenin are rather effective to reduce sleep latency than to act as a sleep-maintaining agent.

Key words

Valeriana officinalis L. - Valerianaceae - linarin - valerenic acid - apigenin - telemetry

References

• 1 Benca R M. Diagnosis and treatment of chronic insomnia: a review.  Psychiatr Serv. 2005;  56 332-343
• 2 Bent S, Padula A, Moore D, Patterson M, Mehling W. Valerian for sleep: a systematic review and meta-analysis.  Am J Med. 2006;  119 1005-1012
• 3 Balderer G, Borbely A A. Effect of valerian on human sleep.  Psychopharmacology (Berl). 1985;  87 406-409
• 4 Brattstroem A. Scientific evidence for a fixed extract combination (ZE 91019) from valerian and hops traditionally used as a sleep-inducing aid.  Wien Med Wochenschr. 2007;  157 367-370
• 5 Diaper A, Hindmarch I. A double-blind, placebo-controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep-disturbed older adults.  Phytother Res. 2004;  18 831-836
• 6 Leathwood P D, Chauffard F. Aqueous extract of valerian reduces latency to fall asleep in man.  Planta Med. 1985;  4 144-148
• 7 Taibi D M, Vitiello M V, Barsness S, Elmer G W, Anderson G D, Landis C A. A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia.  Sleep Med. 2009;  10 319-328
• 8 Benke D, Barberis A, Kopp S, Altmann K H, Schubiger M, Vogt K E, Rudolph U, Möhler H. GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts.  Neuropharmacology. 2009;  56 174-181
• 9 Hattesohl M, Feistel B, Sievers H, Lehnfeld R, Hegger M, Winterhoff H. Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties.  Phytomedicine. 2008;  15 2-15
• 10 Trauner G, Khom S, Baburin I, Benedek B, Hering S, Kopp B. Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid.  Planta Med. 2008;  74 19-24
• 11 Fernandez S, Wasowski C, Paladini A C, Marder M. Sedative and sleep-enhancing properties of linarin, a flavonoid-isolated from Valeriana officinalis.  Pharmacol Biochem Behav. 2004;  77 399-404
• 12 Marder M, Viola H, Wasowski C, Fernandez S, Medina J H, Paladini A C. 6-methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS.  Pharmacol Biochem Behav. 2003;  75 537-545
• 13 Wasowski C, Marder M, Viola H, Medina J H, Paladini A C. Isolation and identification of 6-methylapigenin, a competitive ligand for the brain GABA(A) receptors, from Valeriana wallichii.  Planta Med. 2002;  68 934-936
• 14 Schumacher B, Scholle S, Holzl J, Khudeir N, Hess S, Muller C E. Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptors.  J Nat Prod. 2002;  65 1479-1485
• 15 Leuschner J, Muller J, Rudmann M. Characterisation of the central nervous depressant activity of a commercially available valerian root extract.  Arzneimittelforschung. 1993;  43 638-641
• 16 Hendriks H, Bos R, Woerdenbag H J, Koster A S. Central nervous depressant activity of valerenic acid in the mouse.  Planta Med. 1985;  51 28-31
• 17 Mailliet F, Galloux P, Poisson D. Comparative effects of melatonin, zolpidem and diazepam on sleep, body temperature, blood pressure and heart rate measured by radiotelemetry in wistar rats.  Psychopharmacology (Berl). 2001;  156 417-426
• 18 Weinert D, Waterhouse J. The circadian rhythm of core temperature: effects of physical activity and aging.  Physiol Behav. 2007;  90 246-256
• 19 Campbell E L, Chebib M, Johnston G A. The dietary flavonoids apigenin and (−)-epigallocatechin gallate enhance the positive modulation by diazepam of the activation by GABA of recombinant GABA(A) receptors.  Biochem Pharmacol. 2004;  68 1631-1638
• 20 Berkey D L, Meeuwsen K W, Barney C C. Measurements of core temperature in spontaneously hypertensive rats by radiotelemetry.  Am J Physiol. 1990;  258 R743-R749
• 21 Harkin A, Connor T J, O'Donnell J M, Kelly J P. Physiological and behavioral responses to stress: what does a rat find stressful?.  Lab Anim (NY). 2002;  31 42-50
• 22 Taylor S C, Little H J, Nutt D J, Sellars N. A benzodiazepine agonist and contragonist have hypothermic effects in rodents.  Neuropharmacology. 1985;  24 69-73
• 23 Elliot E E, White J M. The acute effects of zolpidem compared to diazepam and lorazepam using radiotelemetry.  Neuropharmacology. 2001;  40 717-721
• 24 Matthew C B. Telemetry augments the validity of the rat as a model for heat acclimation.  Ann NY Acad Sci. 1997;  813 233-238
• 25 Davies M F, Onaivi E S, Chen S W, Maguire P A, Tsai N F, Loew G H. Evidence for central benzodiazepine receptor heterogeneity from behavior tests.  Pharmacol Biochem Behav. 1994;  49 47-56
• 26 Durcan M J, Morgan P F. Hypothermic effects of alkylxanthines: evidence for a calcium-independent phosphodiesterase action.  Eur J Pharmacol. 1991;  204 15-20
• 27 Pieri L. Preclinical pharmacology of midazolam.  Br J Clin Pharmacol. 1983;  16 (Suppl. 1) 17S-27S
• 28 Schlosberg A J. Temperature responses in rats after acute and chronic administrations of caffeine.  Pharmacol Biochem Behav. 1983;  18 935-942
• 29 Yang J N, Tiselius C, Dare E, Johansson B, Valen G, Fredholm B B. Sex differences in mouse heart rate and body temperature and in their regulation by adenosine A(1) receptors.  Acta Physiol (Oxf). 2007;  190 63-75
• 30 Wagner H, Jurcic K, Schaette R. Comparative studies on the sedative action of Valeriana extracts, valepotriates and their degradation product.  Planta Med. 1980;  39 358-365
• 31 Hiller K O, Zetler G. Neuropharmacological studies on ethanol extracts of Valeriana officinalis l: behavioural and anticonvulsant properties.  Phytother Res. 1996;  10 145-151
• 32 Kakinohana M, Taira Y, Kakinohana O, Okuda Y. The inhibition of lidocaine metabolism by various barbiturates in rat hepatic microsome.  Masui. 1998;  47 1302-1310
• 33 Tokunaga S, Takeda Y, Niimoto T, Nishida N, Kubo T, Ohno T, Matsuura Y, Kawahara Y, Shinomiya K, Kamei C. Effect of valerian extract preparation on the sleep-wake cycle in rats.  Biol Pharm Bull. 2007;  30 363-366
• 34 Hendriks H, Bos R, Allersma D P, Malingre T M, Koster A S. Pharmacological screening of valerenal and some other components of essential oil of Valeriana officinalis.  Planta Med. 1981;  42 62-68
• 35 Viola H, Wasowski C, Levi de Stein M, Wolfman C, Silveira R, Dajas F, Medina J H, Paladini A C. Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects.  Planta Med. 1995;  61 213-216
• 36 Avallone R, Zanoli P, Puia G, Kleinschnitz M, Schreier P, Baraldi M. Pharmacological profile of apigenin, a flavonoid isolated from Matricaria chamomilla.  Biochem Pharmacol. 2000;  59 1387-1394